Top 4 Health Care Stocks That May Plunge This Month
Top 4 Health Care Stocks That May Plunge This Month
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
截至2024年4月26日，醫療保健行業的四隻股票可能會向將動量視爲交易決策關鍵標準的投資者發出真正的警告。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro.
RSI是一個動量指標，它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數高於70時，資產通常被視爲超買。
Here's the latest list of major overbought players in this sector.
以下是該行業主要超買參與者的最新名單。
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
聚變製藥公司（納斯達克股票代碼：FUSN）
- AstraZeneca, through a subsidiary, will acquire all of Fusion's outstanding shares for a price of $21.00 per share in cash at closing plus a non-transferable CVR representing the contingent right to receive $3.00/share in cash payable upon the achievement of a specified regulatory milestone, pursuant and subject to the terms and conditions of a contingent value rights agreement. The company's stock gained around 408% over the past six months and has a 52-week high of $21.55.
- RSI Value: 78.74
- FUSN Price Action: Shares of Fusion Pharmaceuticals closed at $21.40 on Thursday.
- 阿斯利康將通過子公司以收盤時每股現金21.00美元的價格收購Fusion的所有已發行股份，外加不可轉讓的CVR，代表在實現特定監管里程碑後獲得每股3.00美元應付現金的或有權利，但須遵守或有價值權利協議的條款和條件。該公司的股票在過去六個月中上漲了約408％，創下52周高點21.55美元。
- RSI 值：78.74
- FUSN價格走勢：Fusion Pharmicals的股價週四收於21.40美元。
AstraZeneca PLC (NASDAQ:AZN)
阿斯利康公司（納斯達克股票代碼：AZN）
- AstraZeneca reported first-quarter sales of $12.68 billion, up 17% year over year (+19% at constant currency), slightly below the consensus of $11.83 billion. The company's stock gained around 10% over the past five days and has a 52-week high of $75.81.
- RSI Value: 82.50
- AZN Price Action: Shares of AstraZeneca gained 5.4% to close at $75.03 on Thursday.
- 阿斯利康公佈的第一季度銷售額爲126.8億美元，同比增長17％（按固定匯率計算增長19％），略低於市場普遍預期的118.3億美元。該公司的股票在過去五天中上漲了約10％，創下52周高點75.81美元。
- 相對強弱指數值：82.50
- AZN價格走勢：週四，阿斯利康股價上漲5.4％，收於75.03美元。
Boston Scientific Corporation (NYSE:BSX)
波士頓科學公司（紐約證券交易所代碼：BSX）
- On April 24, Boston Scientific reported better than expected first-quarter earnings and issued guidance. The company's stock gained around 8% over the past five days and has a 52-week high of $74.39.
- RSI Value: 76.34
- BSX Price Action: Shares of American Express gained 0.5% to close at $73.26 on Thursday.
- 4月24日，波士頓科學公佈的第一季度收益好於預期，併發布了指引。該公司的股票在過去五天中上漲了約8％，創下52周高點74.39美元。
- RSI 值：76.34
- BSX價格走勢：週四，美國運通股價上漲0.5％，收於73.26美元。
Elevance Health, Inc. (NYSE:ELV)
Elevance Health, Inc.（紐約證券交易所代碼：ELV）
- On April 18, Elevance Health reported first-quarter revenues of $42.3 billion, up 0.9% year over year, marginally missing the consensus of $42.6 billion. "First quarter results reflect disciplined execution of our strategic initiatives during a dynamic time for our industry," CEO Gail Boudreaux said. "We are making significant progress expanding Carelon's capabilities, scaling our flywheel for enterprise growth, and delivering results for all stakeholders." The company's stock jumped around 4% over the past month and has a 52-week high is $542.07.
- RSI Value: 70.18
- ELV Price Action: Shares of Elevance Health gained 1.1% to close at $539.68 on Thursday.
- 4月18日，Elevance Health公佈的第一季度收入爲423億美元，同比增長0.9％，略低於預期的426億美元。首席執行官蓋爾·佈德羅說：“第一季度的業績反映了我們在行業動態時期嚴格執行戰略舉措。”“我們在擴大Carelon的能力、擴大企業增長的飛輪以及爲所有利益相關者交付成果方面正在取得重大進展。”該公司的股票在過去一個月中上漲了約4％，創下52周高點爲542.07美元。
- 相對強弱指數值：70.18
- ELV價格走勢：週四，Elevance Health的股價上漲1.1％，收於539.68美元。
Read More: Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday
閱讀更多：進入週五，微軟、Alphabet和3只股票值得關注
譯文內容由第三人軟體翻譯。